Virulence Factors of Streptococcus Pneumoniae

Streptococcus pneumoniae (pneumococcus) is one of the most common causes of pneumonia, septicemia, and meningitis in children and adults both in developing and developed countries.  S. pneumoniae is the most common causative agent in community-acquired pneumonia (CAP). It produces several virulence factors including polysaccharide capsule, toxin pneumolysin, and enzyme IgA protease that are involved in the disease process.

Autolysin (peptidoglycan hydrolase)

Autolysin is a cell wall degrading enzyme which has the ability to enzymatically disrupt and disintegrate S. pneumoniae. The main autolysin in the pneumococcus is N-acetyl-muramoyl-1-alanine amidase, commonly known as Lyt A. It is thought that when Lyt A is activated the pneumococcal virulence factors such as pneumolysins are released.  Autolysin is responsible to kill the entire culture of S. pneumoniae during its stationary phase. Autolysis usually begins within 18-24 hours of culture with colonies collapsing in the centers.

Schematic diagram of the virulence factors of Streptococcus pneumoniae

IgA1 protease

Immunoglobulin A1 (IgA1) is the predominant immunoglobulin isotype involved in the protection of mucosal membranes of the upper respiratory tract in humans. IgA1 proteases of S. pneumoniae cleaves, thus facilitating colonization and invasion in those surfaces. It is an extracellular bacterial enzyme that specifically cleaves human IgA1 in the hinge region at one of the several postproline peptide bonds (absent in the IgA2 molecule).

A number of other human pathogens such as Haemophilus influenzae, Neisseria meningitidis, Neisseria gonorrhoeae and Ureaplasma urealyticum which infect and invade mucosal membranes also have IgA1 cleaving activity.

Pneumolysin (PLY)

Pneumolysin is a pore-forming toxin of 53 kDa composed of 471 amino acids produced by virtually all clinical isolates of the pneumococcus. At high concentration (above 50 hemolytic units), it lyses all cells having cholesterol (receptor for this toxin) in its surface e.g. it damages respiratory epithelium.

Pneumolysin also may cause a range of effects, including induction of apoptosis, activation of host complement and induce proinflammatory reactions in immune cells.

Polysaccharide capsule:

Polysaccharide capsule completely encloses the cell of Streptococcus pneumoniae and serves as one of the major virulence factor (probably the most important virulence factor). The importance of the S. pneumoniae capsule for virulence is demonstrated by these facts:

  • all clinical isolates of S. pneumoniae causing invasive disease are encapsulated;
  • loss of the capsule by either genetic mutation or enzymatic degradation dramatically reduces S. pneumoniae virulence in animal models of infection
  • different capsular serotypes vary in the ability to cause invasive disease

The capsule may inhibit complement activity (capsule impaired bacterial opsonization with C3b/iC3b by both the alternative and classical complement pathways and also inhibited conversion of C3b bound to the bacterial surface to iC3b) and phagocytosis.  Capsule also prevents mechanical removal by mucus and reduce exposure to antibiotics

For S. pneumoniae strains, there are >93 antigenically distinct capsular serotypes and antibody to the polysaccharide capsule provides type-specific immunity.

Teichoic acids:

Pneumococcal wall teichoic acid is involved in pneumococcal infection of sepsis and adherence to epithelial and endothelial cells. Pneumococcal wall teichoic acid enhances pneumococcal colonization and dissemination.

Other virulence factors of S.pneumoniae includes pneumococcal surface protein A (PspA); protection against complement system, neuraminidase; (may enhances colonization due to its action on glycans) and Pneumococcal surface antigen A etc.

References and Further Reading

About Acharya Tankeshwar 452 Articles
Hello, thank you for visiting my blog. I am Tankeshwar Acharya. Blogging is my passion. I am working as an Asst. Professor and Microbiologist at Department of Microbiology and Immunology, Patan Academy of Health Sciences, Nepal. If you want me to write about any posts that you found confusing/difficult, please mention in the comments below.

1 Comment

  1. Hi Prof! I am a microbiology scientist at the university of Papua New Guinea’s School of Medicine and Health Sciences. I wish to register on the api20E (apiweb) but I’m not sure about the license number it’s asking me to fill out. Any advise on how to have that number so I could utilize the computerized bacterial identification system, please. Or is it just any number I have to fill out and remember? Thank you in advance. Cheers.

Do you have any queries? Please leave me in the comments section below. I will be happy to read your comments and reply.

This site uses Akismet to reduce spam. Learn how your comment data is processed.